Nicholas Shinners

966 total citations
19 papers, 743 citations indexed

About

Nicholas Shinners is a scholar working on Immunology, Oncology and Cancer Research. According to data from OpenAlex, Nicholas Shinners has authored 19 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 12 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Nicholas Shinners's work include CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (5 papers) and NF-κB Signaling Pathways (5 papers). Nicholas Shinners is often cited by papers focused on CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (5 papers) and NF-κB Signaling Pathways (5 papers). Nicholas Shinners collaborates with scholars based in United States and India. Nicholas Shinners's co-authors include Wasif N. Khan, John Lowe, James B. Petro, Gianluca Carlesso, Rachel M. Gerstein, Elliott Kieff, Benjamin E. Gewurz, Kristen L. Hoek, Pierre Antony and Iris Castro and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Nicholas Shinners

19 papers receiving 731 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicholas Shinners United States	12	407	313	214	136	121	19	743
Michael Petrus United States	16	440 1.1×	309 1.0×	190 0.9×	149 1.1×	50 0.4×	24	751
Sanfang Tu China	16	201 0.5×	582 1.9×	297 1.4×	71 0.5×	57 0.5×	52	858
Shinichiro Okabe Japan	13	310 0.8×	145 0.5×	227 1.1×	113 0.8×	72 0.6×	23	872
Selda Samakoglu United States	12	165 0.4×	353 1.1×	188 0.9×	258 1.9×	56 0.5×	20	635
Giulia Spallone Italy	12	218 0.5×	136 0.4×	237 1.1×	63 0.5×	72 0.6×	27	609
Lauren Fairchild United States	7	498 1.2×	488 1.6×	359 1.7×	49 0.4×	150 1.2×	17	896
Shamaila Munir Ahmad Denmark	18	514 1.3×	422 1.3×	171 0.8×	41 0.3×	56 0.5×	29	790
Huiping Gao China	12	392 1.0×	616 2.0×	248 1.2×	60 0.4×	66 0.5×	22	889
Amy J. Petty United States	11	497 1.2×	344 1.1×	271 1.3×	47 0.3×	88 0.7×	20	854
Ming‐Chao Zhong Canada	21	916 2.3×	300 1.0×	232 1.1×	72 0.5×	58 0.5×	30	1.1k

Countries citing papers authored by Nicholas Shinners

Since Specialization

Citations

This map shows the geographic impact of Nicholas Shinners's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Shinners with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Shinners more than expected).

Fields of papers citing papers by Nicholas Shinners

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Shinners. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Shinners. The network helps show where Nicholas Shinners may publish in the future.

Co-authorship network of co-authors of Nicholas Shinners

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas Shinners. A scholar is included among the top collaborators of Nicholas Shinners based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas Shinners. Nicholas Shinners is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Collinson-Pautz, Matthew R., Wei-Chun Chang, An Lu, et al.. (2019). Constitutively active MyD88/CD40 costimulation enhances expansion and efficacy of chimeric antigen receptor T cells targeting hematological malignancies. Leukemia. 33(9). 2195–2207. 64 indexed citations

Mackay, Sean, Brianna Flynn, Colin Ng, et al.. (2017). Single-Cell Multiplex Proteomics Reveals Synergistic Impact of Antigen and Rimiducid-Dependent Stimulatory Signals on Promoting Polyfunctional GoCAR-T Cells Targeting Prostate Stem Cell Antigen (PSCA). Blood. 130. 2281–2281. 1 indexed citations

Foster, Aaron E., Aruna Mahendravada, Nicholas Shinners, et al.. (2017). Regulated Expansion and Survival of Chimeric Antigen Receptor-Modified T Cells Using Small Molecule-Dependent Inducible MyD88/CD40. Molecular Therapy. 25(9). 2176–2188. 93 indexed citations

Havránek, Ondřej, Jingda Xu, Stefan Köhrer, et al.. (2017). Tonic B-cell receptor signaling in diffuse large B-cell lymphoma. Blood. 130(8). 995–1006. 66 indexed citations

Foster, Aaron E., MyLinh Duong, An Lu, et al.. (2016). Inducible MyD88/CD40 (iMC) Costimulation Provides Ligand-Dependent Tumor Eradication By CD123-Specific Chimeric Antigen Receptor T Cells. Blood. 128(22). 4551–4551. 2 indexed citations

Slawin, Kevin M., Aruna Mahendravada, Nicholas Shinners, et al.. (2016). Inducible MyD88/CD40 to allow rimiducid-dependent activation for control of proliferation and survival of chimeric antigen receptor (CAR) T cells targeting prostate stem cell antigen (PSCA).. Journal of Clinical Oncology. 34(2_suppl). 206–206. 2 indexed citations

Foster, Aaron E., Aruna Mahendravada, Nicholas Shinners, et al.. (2015). Inducible MyD88/CD40 Allows Rimiducid-Dependent Activation to Control Proliferation and Survival of Chimeric Antigen Receptor-Modified T Cells. Blood. 126(23). 4295–4295. 2 indexed citations

Havránek, Ondřej, Stefan Koehrer, Zhiqiang Wang, et al.. (2014). The B-Cell Receptor Is Required for Optimal Viability, Growth, and Chemotherapy Resistance of Diffuse Large B-Cell Lymphoma Cell Lines of the Germinal Center B-Cell Subtype. Blood. 124(21). 493–493. 3 indexed citations

Foster, Aaron E., Aruna Mahendravada, Peter S. Chang, et al.. (2014). Inducible MyD88/CD40 Allows AP1903-Dependent Costimulation to Control Proliferation and Survival of Chimeric Antigen Receptor-Modified T Cells. Blood. 124(21). 1121–1121. 1 indexed citations

10.

Gewurz, Benjamin E., Fadi Towfic, Jessica C. Mar, et al.. (2012). Genome-wide siRNA screen for mediators of NF-κB activation. Proceedings of the National Academy of Sciences. 109(7). 2467–2472. 82 indexed citations

11.

Gewurz, Benjamin E., Jessica C. Mar, Megha Padi, et al.. (2011). Canonical NF-κB Activation Is Essential for Epstein-Barr Virus Latent Membrane Protein 1 TES2/CTAR2 Gene Regulation. Journal of Virology. 85(13). 6764–6773. 41 indexed citations

12.

Castro, Iris, Jacqueline A. Wright, Bazarragchaa Damdinsuren, et al.. (2009). B Cell Receptor-Mediated Sustained c-Rel Activation Facilitates Late Transitional B Cell Survival through Control of B Cell Activating Factor Receptor and NF-κB2. The Journal of Immunology. 182(12). 7729–7737. 40 indexed citations

13.

Song, Yoon‐Jae, Kenneth M. Izumi, Nicholas Shinners, Benjamin E. Gewurz, & Elliott Kieff. (2008). IRF7 activation by Epstein–Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3. Proceedings of the National Academy of Sciences. 105(47). 18448–18453. 44 indexed citations

14.

Shinners, Nicholas, Gianluca Carlesso, Isac de Castro, et al.. (2007). Bruton’s tyrosine kinase mediates NF-κB activation and B cell survival by B cell-activating factor receptor of the TNF-R family. The Journal of Immunology. 179(9). 6369–6369. 2 indexed citations

15.

Shinners, Nicholas, Gianluca Carlesso, Iris Castro, et al.. (2007). Bruton’s Tyrosine Kinase Mediates NF-κB Activation and B Cell Survival by B Cell-Activating Factor Receptor of the TNF-R Family. The Journal of Immunology. 179(6). 3872–3880. 96 indexed citations

16.

Hoek, Kristen L., Pierre Antony, John Lowe, et al.. (2006). Transitional B Cell Fate Is Associated with Developmental Stage-Specific Regulation of Diacylglycerol and Calcium Signaling upon B Cell Receptor Engagement. The Journal of Immunology. 177(8). 5405–5413. 33 indexed citations

17.

Antony, Pierre, James B. Petro, Gianluca Carlesso, et al.. (2004). B-cell antigen receptor activates transcription factors NFAT (nuclear factor of activated T-cells) and NF-κB (nuclear factor κB) via a mechanism that involves diacylglycerol. Biochemical Society Transactions. 32(1). 113–115. 29 indexed citations

18.

Antony, Pierre, James B. Petro, Gianluca Carlesso, et al.. (2003). B Cell receptor directs the activation of NFAT and NF-κB via distinct molecular mechanisms. Experimental Cell Research. 291(1). 11–24. 46 indexed citations

19.

Petro, James B., et al.. (2002). Transitional Type 1 and 2 B Lymphocyte Subsets Are Differentially Responsive to Antigen Receptor Signaling. Journal of Biological Chemistry. 277(50). 48009–48019. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact